drugset / Trial / NCT00755170
Metronomic Vinorelbine and Bevacizumab in Patients With Non Small Cell Lung Cancer
Phase 2
Completed
48 enrolled
Hellenic Oncology Research Group
University Hospital of Crete · collab
NaSingle-groupOpen-labelTreatment
Summary
This trial will evaluate the efficacy and safety of metronomic vinorelbine and bevacizumab combination in patients with pretreated, advanced non small cell lung cancer
Timeline
- Start
- 2008-11
- Primary completion
- 2016-10
- Completion
- 2016-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bevacizumab | Monoclonal antibody | 10 mg/kg | Intravenous |
| Subject | Vinorelbine | Small molecule | 30 mg | Oral |